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ABSTRACT. 
Anthrax is caused by the organism Bacillus anthracis. The organism is 
globally occurring and epidemics are reported the world over. It is an 
important infectious disease of domestic animals. B. anthracis can survive 
harsh conditions that would otherwise be drastic for other microorganisms. 
The inherently robust nature of the organism enables its extended survival 
and facilitates re-emergence. To date, no outbreak has been reported in the 
Pacific Island region except Australia and New Zealand where outbreaks are 
reported in both wildlife and livestock. Papua New Guinea has had sporadic 
(reported) instances of anthrax outbreak, but has not been scientifically 
established. It is still unclear if the anthrax causing organism is present in 
the environment or wildlife. It remains to be so until scientific evidence 
becomes available. This article aims to review any form of documented 
evidence of anthrax in the countr. 
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1 Introduction 
Anthrax is caused by the bacteria, B. anthracis. A gram-stained morphology of B. anthracis 
colony appears as gram positive rods, often linked at lengthwise to form a chain (Murray et al. 
1990; Brooks et al. 1991; Spencer 2003; Schaechter et al. 2006; MA Hornitzky and Muller 2010; 
Todar 2012). It is ubiquitous; survives in both soil and vegetation, and can resist adverse 
conditions (Turnbull et al. 1998; Murray et al. 1990; Spencer 2003; Schaechter et al. 2006; 
Veterinary Services 2012). Anthrax is neither contagious nor invasive; however, it causes acute 
infection in susceptible animals (Fasanella and Garofolo 2008; Beyer and Turnbull 2009; 
Stoltenow et al. 2010). The organism is vegetative in host tissues but sporulates when exposed 
to the environment (Woodbury et al. 2002; Spencer 2003; Schaechter et al. 2006; Stoltenow et 
al. 2010). Sporulation shields the organism from unfavourable conditions and enables it to 
survive for years until it gets re-inoculated in another living host thereby continuing its vicious 
cycle of infection (Massachusetts Department of Public Health 2006; Schaechter et al. 2006; 
Fasanella and Garofolo 2008; Todar 2012) . In contrast to other zoonoses, anthrax affects a 
wide range of animals including human (Murray et al. 1990; Brooks et al. 1991; Spencer 2003; 
Beyer and Turnbull 2009; Stoltenow et al. 2010). It is believed that animals acquire the infection 
through ingestion of tainted feed or while foraging on contaminated field (Tweet 2010; 
Veterinary Services 2012). Nevertheless, human unintentionally contract it, usually through the 
skin while handling infected animals or their products (Turnbull et al. 1998; Ron Parker et al. 
2002; Spencer 2003; Edwards et al. 2005; Beyer and Turnbull 2009; Todar 2012). Inhalation of 
the contaminated aerosol or ingestion of partly cooked meat has also been observed (Edwards 
et al. 2005; Fasanella and Garofolo 2008; Stoltenow et al. 2010; Todar 2012; Hajramurni 2013). 
 
 
2 Epidemiology 
Anthrax is caused by the bacteria, B. anthracis. A gram-stained morphology of B. anthracis 
colony appears as gram positive rods, often linked at lengthwise to form a chain (Murray et al. 
1990; Brooks et al. 1991; Spencer 2003; Schaechter et al. 2006; Hornitzky and Muller 2010; 
Todar 2012). It is ubiquitous; survives in both soil and vegetation, and can resist adverse 
conditions (Turnbull et al. 1998; Murray et al. 1990; Spencer 2003; Schaechter et al. 2006; 
Veterinary Services 2012). Anthrax is neither contagious nor invasive; however, it causes acute 
infection in susceptible animals (Fasanella and Garofolo 2008; Beyer and Turnbull 2009; 
Stoltenow et al. 2010). The organism is vegetative in host tissues but sporulates when exposed 
to the environment (Parker et al. 2002; Spencer 2003; Schaechter et al. 2006; Stoltenow et al. 
2010). Sporulation shields the organism from unfavourable conditions and enables it to survive 
for years until it gets re-inoculated in another living host thereby continuing its vicious cycle of 
infection (Massachusetts Department of Public Health 2006; Schaechter et al. 2006; Fasanella 
and Garofolo 2008; Todar 2012) . In contrast to other zoonoses, anthrax affects a wide range 
of animals including human (Murray et al. 1990; Brooks et al. 1991; Spencer 2003; Beyer and 
Turnbull. 2009; Stoltenow et al. 2010). It is believed that animals acquire the infection through 
ingestion of tainted feed or while foraging on contaminated field (Tweet 2010; Veterinary 
Services 2012). Nevertheless, human unintentionally contract it, usually through the skin while 
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handling infected animals or their products (Turnbull et al. 1998 ; Parker et al. 2002; Spencer 
2003; Edwards et al. 2005; Beyer and Turnbull. 2009; Todar 2012). Inhalation of the 
contaminated aerosol or ingestion of partly cooked meat has also been observed (Edwards et 
al. 2005; Fasanella and Garofolo 2008; Stoltenow et al. 2010; Todar 2012; Hajramurni 2013). 
 
 
3 Acquisition 
Anthrax is caused by the bacteria, B. anthracis. A gram-stained morphology of B. anthracis 
colony appears as gram positive rods, often linked at lengthwise to form a chain (Murray et al. 
1990; Brooks et al. 1991; Spencer 2003; Schaechter et al. 2006; Hornitzky and Muller 2010; 
Todar 2012). It is ubiquitous; survives in both soil and vegetation, and can resist adverse 
conditions (Turnbull et al. 1998; Murray, Drew et al. 1990; Spencer 2003; Schaechter et al. 2006; 
Veterinary Services 2012). Anthrax is neither contagious nor invasive; however, it causes acute 
infection in susceptible animals (Fasanella and Garofolo 2008; Beyer and Turnbull 2009; 
Stoltenow et al. 2010). The organism is vegetative in host tissues but sporulates when exposed 
to the environment (Parker et al. 2002; Spencer 2003; Schaechter et al. 2006; Stoltenow et al. 
2010). Sporulation shields the organism from unfavourable conditions and enables it to survive 
for years until it gets re-inoculated in another living host thereby continuing its vicious cycle of 
infection (Massachusetts Department of Public Health 2006; Schaechter et al. 2006; Fasanella 
and Garofolo 2008; Todar 2012) . In contrast to other zoonoses, anthrax affects a wide range 
of animals including human (Murray et al. 1990; Brooks et al. 1991; Spencer 2003; Beyer and 
Turnbull. 2009; Stoltenow et al. 2010). It is believed that animals acquire the infection through 
ingestion of tainted feed or while foraging on contaminated field (Tweet 2010; Veterinary 
Services 2012). Nevertheless, human unintentionally contract it, usually through the skin while 
handling infected animals or their products (Turnbull et al. 1998; Parker et al. 2002; Spencer 
2003; Edwards et al. 2005; Beyer and Turnbull 2009; Todar 2012). Inhalation of the 
contaminated aerosol or ingestion of partly cooked meat has also been observed (Edwards et 
al. 2005; Fasanella and Garofolo 2008; Stoltenow et al. 2010; Todar 2012; Hajramurni 2013). 
 
 
4 Pathogenesis 
The anthrax pathogenesis initiates when the spore enters the skin through lesions, lungs 
via inhalation or intestines from ingestion of contaminated meat (Turnbull et al. 1998; Spencer 
2003; Todar 2012). In the tissues, the spores are engulfed and ingested by resident or 
migratory macrophages. Secured spores are then presented to regional lymph nodes (Hanna 
1993; Bush et al. 2001; Missiakas and MD 2005; Sherer et al. 2007). Due to the capsulated cell 
wall, the spores evade phagocytosis and eventually vegetate. At this stage, germinated cells 
exhibit its virulence and toxin factors (Spencer 2003; Edwards et al. 2005; Schaechter et al. 
2006; Todar 2012). Productions of edema toxins induce blistering and necrotic lesions as in 
skins (Murray et al. 1990; Brooks et al. 1991; Missiakas and MD 2005). In the intestinal mucosa 
and alveoli, massive effusion and edema ensues leaving behind necrotising tissues the sum of 
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which triggers inflammatory responses. The combination of lethal toxins results in impaired 
immune response, host cell destruction and spread of bacterial infection (Hanna 1993; Spencer 
2003; Quinn et al. 2004; Edwards et al. 2005; Missiakas and MD 2005; Ebrahimi et al. 2011). In 
time, the bacterium reaches the blood stream causing septicaemia, respiratory distress, 
meningitis and eventually death. 
 
 
5 Control measures in the event of an anthrax outbreak 
As with other emerging infectious diseases, environmental and syndromic surveillance is 
crucial for prompt detection and control of anthrax outbreak in Papua New Guinea (Paul 
Horwood and Greenhill 2012). The potential for re-emergence and sporadic occurrence of 
anthrax is high due its innate ability to survive in nature (Turnbull et al. 1998; Spencer 2003; 
Durrheim et al. 2009). An outbreak in one kind of domestic animal can easily spread to other 
species since local animals in rural Papua New Guinea are free-ranging and often share the 
same surrounding (Hide 2003; Durrheim et al. 2009). 
Environmental contamination of anthrax may arise from infected animal carcass being 
disposed off arbitrarily (Fasanella and Garofolo 2008; Stoltenow et al. 2010; Tweet 2010). This 
raises concern since the environment is a natural reservoir for B. anthracis or facilitates cross-
infection of other animals that might feed on the carcass (Stoltenow et al. 2010). In view of 
this, burying of infected animals should be discouraged as the organism will endure long after 
the carcass disintegrates and disappears. Incineration of infected carcass in situ is important to 
minimise shedding of pathogenic agents in the environment that might serve as a reservoir for 
future infection (Caledonia et al. 2002; Fasanella and Garofolo 2008; Stoltenow et al. 2010; 
Australia 2012; Veterinary Services 2012). Isolation for vaccination or treatment and culling of 
infected animals, particularly the terminally ill or nearing dead are crucial to curb transmission 
and future outbreak of anthrax (Tweet 2010). However, culling may not be practised in rural 
settings. Even though the sudden death of one or more animal might stir inquisition, 
investigation of such occurrence by trained personnel is rarely expected. Remoteness of sites 
and funding limitation tends to be the usual impediment to such effort. 
Vaccination is an effective control measure as it offers valuable protection for susceptible 
animals. It has proven to be successful during outbreak in animal herds (Gill 1993; Turner et al. 
1999; Allan 2014; Tweet 2010). Human vaccination is purely recommended for individuals that 
deal with the organism as in laboratory facilities or livestock handlers where anthrax outbreak 
is endemic. Most cases of human anthrax are attributed to direct contact with infected animals 
or its products (WHO 2008; Stoltenow et al. 2010). Therefore, vaccination of susceptible 
animals not only protects them, but prevents the basic route whereby humans contract the 
infection. Nevertheless, animal vaccination is recommended just about the period when 
outbreak is detected (Turnbull et al. 1998; Gill 1993; Turner et al. 1999; Parker et al. 2002; Hide 
2003; Spencer 2003; Fasanella and Garofolo 2008; Stoltenow et al. 2010; Hornitzky and Muller 
2010; Tweet 2010; Veterinary Services 2012). 
Proper Personal Protection Equipment (PPE) is mandatory for any form of anthrax-related 
work or epidemiological response. They include: face masks or visor (if available but gas masks 
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are highly recommended), goggles, boots gloves and overalls with hoods. These are single-use 
equipment and should be incinerated afterwards or thoroughly sterilized if re-usable. 
 
 
6 Laboratory Diagnosis  
It is a safety requirement that a laboratory facility dealing with anthrax should operate in a 
Level 2 Biosafety Cabinet and the laboratory personnel thoroughly attired in PPE. Level 3 BC is 
better still, if the amount of work is substantial or the potential for generating aerosols is high 
(Turnbull et al. 1998). Blood culture is routinely performed on virtually all suspected cases of B. 
anthracis infection (Veterinary Services 2012). Initial presumptive identification of B. anthracis 
can be performed through rapid test kits such as Immuno-chromatographic tests, using serum 
sample of infected animal or human (Hornitzky and Muller 2010). Smears for staining and 
microscopic examination can be obtained by swab from lesions, tissue fluids or blood sample. 
Heat-fixation is not applicable for B. anthracis as it not thoroughly bactericidal therefore; 
smears should be immersed in 40 percent potassium permanganate solution for at least 10 
minutes (Cheeesborough 2000). Both gram stain and Loeffler’s polychrome methylene blue 
staining are acceptable (Turnbull et al. 1998; Cheeesborough 2000; WHO 2008; Australia 2012). 
However, Loeffler’s polychrome methylene blue staining depicts the encapsulated bacillus 
which is a clear, but presumptive identification of B. anthracis (Spencer 2003; WHO 2008). 
Further work up and confirmation would require pure culture and isolation, ELISA techniques, 
and if available PCR for definite diagnosis and genetic studies (Hornitzky and Muller 2010; 
Australia 2012).  
 
 
7 Treatment options 
The acute nature of anthrax infection warrants prompt treatment. If delayed, it could lead 
to serious complications and even death. Hospitalisation is necessary in virtually all cases of 
anthrax infection. The ‘CDC Guidelines for the Treatment of Anthrax’ recommends the use of 
regular antibiotics including; ciprofloxacin, doxycycline, and penicillin for treatment 
(Prevention 2014). A large dose, administered both intravenously and orally over couple 
months is suggested for very serious cases of B. anthracis infections as it takes about such 
length of time for spores to germinate (Vyas 2013). The optimal antibiotic, dosage level, route 
of administration and the length of treatment may vary with patient and degree of infection. 
These basic antibiotic treatment options are available in Papua New Guinea. However, advance 
infections may necessitate the use of antitoxins (Vyas 2013; Administration 2012). The United 
States Food and Drug Administration have recommended the use of monoclonal antibodies to 
counteract bacterial toxins which are responsible for the irreparable tissue damage caused 
during the course of infection (Administration 2012). 
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8 Conclusion 
No human case of anthrax has been reported in Papua New Guinea. If at all, there is no 
documentation or clinical evaluation of a patient that would otherwise suggest a probable 
infection. It is worth mentioning particularly, when Papua New Guinea is considered as anthrax 
endemic while other Pacific Island nations are deemed to be free (Caledonia, Community et al. 
2002; Fasanella and Garofolo 2008; Stoltenow et al. 2010). Nevertheless, one case of an 
unknown disease outbreak in pigs in a remote area in Papua New Guinea has been reported. 
This report claimed that three people have died consuming pork from a carcass thought to 
have died from anthrax. However, it has never been established if B. anthracis was responsible. 
Animal infections were reportedly observed in porcine and village pigs which are commonest 
form of domesticated animals in the highlands region of Papua New Guinea (Hide 2003; 
Fasanella and Garofolo 2008; Stoltenow et al. 2010; Provet 2013). Still, no human infection has 
been reported despite the fact that local highlanders live in close proximity to native animals. 
Other than these, there is no documented evidence of infection in other animals including 
wildlife or livestock. Concrete scientific data is needed to establish the presence of B. anthracis 
in native animals, wildlife or the environment in Papua New Guinea. 
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